Showing 38,481 - 38,500 results of 100,274 for search '(( 5 teer decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.76s Refine Results
  1. 38481
  2. 38482
  3. 38483
  4. 38484

    DataSheet_2_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

    Published 2022
    “…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).</p>Results<p>The humoral immune response in the “vaccination” cohort was higher at 3 months, but lower at 10 months, compared to the “infection” cohort due to a faster decline. …”
  5. 38485

    DataSheet_1_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

    Published 2022
    “…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).</p>Results<p>The humoral immune response in the “vaccination” cohort was higher at 3 months, but lower at 10 months, compared to the “infection” cohort due to a faster decline. …”
  6. 38486

    DataSheet_2_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

    Published 2022
    “…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).</p>Results<p>The humoral immune response in the “vaccination” cohort was higher at 3 months, but lower at 10 months, compared to the “infection” cohort due to a faster decline. …”
  7. 38487

    DataSheet_1_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

    Published 2022
    “…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).</p>Results<p>The humoral immune response in the “vaccination” cohort was higher at 3 months, but lower at 10 months, compared to the “infection” cohort due to a faster decline. …”
  8. 38488
  9. 38489
  10. 38490

    Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer by Kelly Coffey (129302)

    Published 2012
    “…<div><p>Tip60 (KAT5) is a histone acetyltransferase (HAT enzyme) involved in multiple cellular processes including transcriptional regulation, DNA damage repair and cell signalling. …”
  11. 38491
  12. 38492
  13. 38493

    <sup>99m</sup>Tc-Labeled RGD-BBN Peptide for Small-Animal SPECT/CT of Lung Carcinoma by Zhaofei Liu (1583062)

    Published 2012
    “…We recently designed and synthesized a Glu-c­(RGDyK)-bombesin (RGD-BBN) heterodimeric peptide exhibiting a dual integrin α<sub>v</sub>β<sub>3</sub> and gastrin-releasing peptide receptor (GRPR) targeting property. …”
  14. 38494

    Follow-up outcomes of asymptomatic brucellosis: a systematic review and meta-analysis by Fande Li (11457104)

    Published 2023
    “…Regarding the follow-up outcomes, we examined the presence or absence of symptoms and decreased serum agglutination test (SAT) titre. During the 0.5–18 months follow-up period, the pooled prevalence of appearing symptomatic was 15.4% (95% CI 2.1%–34.3%), cases that remained asymptomatic were 40.3% (95% CI 16.6%–65.8%), and decreased SAT titre was observed in 36.5% (95% CI 11.6%–66.1%). …”
  15. 38495
  16. 38496
  17. 38497
  18. 38498

    Table_2_Biomarkers in long COVID-19: A systematic review.xlsx by Yun-Ju Lai (599120)

    Published 2023
    “…Compared with healthy control or recovered patients without long COVID symptoms, 79 biomarkers were increased, 29 were decreased, and 5 required further determination in the long COVID patients. …”
  19. 38499

    Table_3_Biomarkers in long COVID-19: A systematic review.pdf by Yun-Ju Lai (599120)

    Published 2023
    “…Compared with healthy control or recovered patients without long COVID symptoms, 79 biomarkers were increased, 29 were decreased, and 5 required further determination in the long COVID patients. …”
  20. 38500

    C1 acts as a chemoattractant but did not influence microglial motility and phagocytosis. by Philipp Jordan (9364068)

    Published 2023
    “…<b>c)</b> The phagocytic activity both under basal conditions (left, ctrl.) and LPS stimulated conditions (right, +LPS) was assessed using a FACS-based protocol. Microglia were pre-treated with 2.5 μM C1 in DMSO (red) or its corresponding concentration of DMSO (in grey,125x10<sup>-5</sup> v/v) and compared to the control medium. …”